Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Alere Inc    ALR   US01449J1051

ALERE INC (ALR)

3
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Alere Inc : Alere Inc. Schedules Conference Call for 8:30 a.m. ET February 8, 2012 to Discuss Fourth Quarter 2011 Results

02/01/2012 | 03:20pm US/Eastern

WALTHAM, Mass., Feb. 1, 2012 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced that it will release its fourth quarter 2011 earnings on Wednesday, February 8, 2012. The Company will also host a conference call beginning at 8:30 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call, the Company will discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.

The conference call may be accessed by dialing (800) 860-2442 (domestic) or (412) 858-4600 (international) and asking for Alere Inc. A webcast of the call can also be accessed via the Alere website at www.alere.com/investors, or directly through the following link: http://www.videonewswire.com/event.

A replay will be available approximately four hours after the conclusion of the call and will remain available for a period of seven days following the call. The replay may be accessed by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international) and entering replay code 10009812. The replay will also be available via online webcast at http://www.videonewswire.com/event or via the Alere website at www.alere.com/investors for a period of 60 days following the call.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, toxicology and women's health. Alere is headquartered in Waltham, Massachusetts.

For additional information on Alere, please visit www.alere.com.

SOURCE Alere Inc.

Latest news on ALERE INC
3d ago ALERE : Completion of Acquisition or Disposition of Assets, Financial Statements..
10/07 ALERE : Analytics CMO to Present at the US News & World Report Hospital of Tomor..
10/02 ALERE : Dr. Fauzia Khan, CMO of Alere Analytics, to Provide Healthcare Insights ..
10/02 ALERE : Entamoeba histolytica Rapid Test Receives CE Mark
10/01 ALERE : HHS pursues detection tests for influenza
10/01 ALERE : Awarded U.S. Government Contract to Advance Development of Point-of-Care..
09/30 ALERE : Webinar Spotlights Optimal Flu Diagnostics to Keep Your Lab Ahead of the..
09/30 ALERE : African First Ladies to Launch OAFLA's Push to Eliminate Mother-to- Chil..
09/26 ALERE : SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Propo..
09/26 ALERE : NYSE:ALR) Investor Alert: Investigation of Takeover at $46.00 Per Share
Dynamic quotes  
ON
| OFF